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Background: Visceral leishmaniasis (VL) remains as one of the most neglected tropical diseases with over 60% of
the world’s total VL cases occurring in the Indian subcontinent. Due to the invasive risky procedure and technical
expertise required in the classical parasitological diagnosis, the goal of the VL experts has been to develop
noninvasive procedure(s) applicable in the field settings. Several serological and molecular biological approaches
have been developed over the last decades, but only a few are applicable in field settings that can be performed
with relative ease. Recently, loop-mediated isothermal amplification (LAMP) has emerged as a novel nucleic acid
amplification method for diagnosis of VL. In this study, we have evaluated the LAMP assay using buffy coat DNA
samples from VL patients in Bangladesh and compared its performance with leishmania nested PCR (Ln-PCR), an
established molecular method with very high diagnostic indices.
Methods: Seventy five (75) parasitologically confirmed VL patients by spleen smear microcopy and 101 controls
(endemic healthy controls −25, non-endemic healthy control-26, Tuberculosis-25 and other diseases-25) were
enrolled in this study. LAMP assay was carried out using a set of four primers targeting L. donovani kinetoplast
minicircle DNA under isothermal (62 °C) conditions in a heat block. For Ln-PCR, we used primers targeting the
parasite’s small-subunit rRNA region.
Results: LAMP assay was found to be positive in 68 of 75 confirmed VL cases, and revealed its diagnostic
sensitivity of 90.7% (95.84-81.14, 95% CI), whereas all controls were negative by LAMP assay, indicating a specificity
of 100% (100–95.43, 95% CI). The Ln-PCR yielded a sensitivity of 96% (98.96-87.97, 95% CI) and a specificity of
100% (100–95.43, 95% CI).
Conclusion: High diagnostic sensitivity and excellent specificity were observed in this first report of LAMP
diagnostic evaluation from Bangladesh. Considering its many fold advantages over conventional PCR and potential
to be used as a simple and rapid test in the VL endemic areas of the Indian subcontinent, our findings are
encouraging, but further evaluation of LAMP is needed.
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Visceral leishmaniasis (VL) is considered as one of the
most neglected tropical diseases. In the Indian subcon-
tinent VL is mainly caused by the intracellular protozoan
parasite Leishmania donovani and transmitted exclu-
sively by the bite of the sandfly, Phlebotomous argen-
tipes. The annual incidence worldwide is approximately
0.2 to 0.4 million cases with mortality rates of 1.5% (93
deaths/6224 VL cases from 2004–2008) in Bangladesh
[1]. Surprisingly, over 60% of the world’s VL cases occur
in three countries of the Indian subcontinent (India,
Bangladesh and Nepal) with 40,000 or more reported
cases per year [2].
Diagnosis of VL is still a great challenge and is cum-
bersome, especially in the resource limited settings of
the Indian subcontinent. Definitive diagnosis of VL is of
paramount importance to provide a specific treatment
regimen as well as in understanding the disease epidemi-
ology. Parasitological confirmation of VL through mi-
croscopy still relies on invasive procedure like spleen,
bone-marrow or lymph-node aspiration. Involvement of
substantial risk and skilled personnel are among the
major limitations associated with these procedures, so
access to such diagnostic facilities is far beyond the
reach of most of the poor people affected with VL living
in the remote rural areas.
Efforts are evolving continuously to develop diagnostic
methods for VL but existing ones still have some limita-
tions. Serological methods like direct agglutination test
(DAT) and rK39 (recombinant k39 antigen-based immu-
nochromatographic strip test) dipstick are now well
standardized [3-5], but these tests are only for antibody
detection and assessment of cure after treatment and
discrimination between symptomatic and asymptomatic
cases is not possible. Moreover, cross reactivity with
other diseases and inconsistent performance in the case
of HIV-VL co-infection are among other major obstacles
of the serological tests [6]. Antigen detection from urine
through latex agglutination test (KAtex) could be an-
other promising tool for direct diagnosis of VL but poor
to moderate sensitivities have been revealed in several
studies [7-9] that restrict its use in the field settings.
Polymerase Chain Reaction (PCR) has been developed
and evaluated as a potent tool for rapid and sensitive de-
tection of Leishmania DNA from peripheral blood and
buffy coat which is ideal for minimal invasive procedure
[10-12]. However, PCR is neither a pragmatic or cost ef-
fective method for diagnosis of VL in developing coun-
tries such as the Indian subcontinent, as it requires a
well-established laboratory and skilled personnel. Re-
cently, a promising diagnostic tool, loop-mediated iso-
thermal amplification (LAMP) has been developed with
its potential for not only rapid and sensitive diagnosis
but also its feasibility as an alternative technique toconventional PCR method in field conditions [13].
LAMP assay has also been established to detect Leish-
mania donovani DNA from blood samples of VL
patients and the results were comparable with that of
conventional PCR [14].
This prospective study was designed to evaluate the
diagnostic accuracy of LAMP for rapid and sensitive de-
tection of L. donovani DNA from buffy coat of con-
firmed VL patients and to examine its efficacy as a
diagnostic alternative to PCR.
Methods
Ethical approval
Ethical clearance was obtained from the International
Centre for Diarrhoeal Disease Research, Bangladesh
(ICDDR, B), ethical review committee. Informed written
consent was obtained from each patient or from their
legal guardian before splenic aspiration and venipunc-
ture. Written consent was also obtained from all con-
trols before including their samples in the study.
Patients
A total of 75 confirmed VL patients were enrolled in the
study. All of the subjects were admitted to Rajshahi
Medical College Hospital (RMCH), Bangladesh from
January 2010 to October 2011. The definitive diagnosis
of VL was based on the microscopic demonstration of
Leishmania amastigotes in the splenic aspiration smear.
Controls
A total of 101 subjects were enrolled in this study as
control. The controls were divided into three categories.
Twenty five (25) endemic healthy controls were col-
lected from Godagari sub district, a highly endemic area
of VL in the Rajshahi division, Bangladesh. Twenty six
(26) apparently healthy controls without any signs and
symptoms of present VL or past history of VL were also
enrolled from VL non endemic areas. Fifty (50) disease
controls, including 25 tuberculosis patients confirmed as
sputum positive for acid fast bacilli (AFB) by microscopy
from the National Institute of Diseases of Chest and
Hospital (NIDCH), Mohakhali, Dhaka and another
25 patients with other febrile diseases (Acute Lympho-
blastic Leukemia 2, Acute Myeloid Leukemia 1, Aplastic
anaemia 1, Chronic Liver Disease 3, Chronic Myeloid
Leukemia 3, Enteric fever 2, L. vulguris 1, Liver Abscess
1, Pyrexia of Unknown Origin 3, Rheumatic fever 1,
SOL in spleen 1, Thalassemia 5, Viral hepatitis 1) having
fever for more than 2 weeks and admitted into different
wards of RMCH were also included in the study.
Case definition
Confirmed VL patients were selected based on splenic
smear positive for L. donovani amastigote.
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Splenic aspiration was performed after excluding contra-
indications for the procedure in each case by an experi-
enced doctor following standard technique as described
by Bryceson et al. [15]. In every instance, two good
quality smears were prepared by a proficient laboratory
technician and stained with Leishman stain. The smear
was read in a standardized way under 10 × 100 mag-
nification of a CH-20 Olympus microscope (Model
CH20BIMF200, Olympus Optical Co., Ltd. JAPAN) for
the presence of L. donovani amastigotes by an experi-
enced microscopist at the department of Microbiology
of Rajshahi Medical College (RMC). Presence of LD
bodies was graded on a scale from 1+ to 6+. If the num-
ber of amastigotes counted per field was >100, 10–100
or 1–10, it was graded as 6+, 5+ and 4+ respectively.
Similarly, 1–10 amastigotes in 10, 100 or 1000 fields
were graded as 3+, 2+ and 1+ respectively [15]
Buffy coat preparation
Maintaining good clinical practice, 3.0 mL of venous
blood was collected in vacuette (K3 EDTA tube) from
all subjects. Immediately after collection, blood was cen-
trifuged by density gradient centrifugation with an equal
volume of Histopaque 1119 (Sigma Aldrich, USA). After
centrifugation, plasma and buffy coat samples were
transferred into two different sterile 1.5 mL micro-
centrifuge tubes and stored at −20°C at RMC until ship-
ment to ICDDR, B. The samples were transferred period-
ically to ICDDR, B maintaining cold chain.rK39 RDT
For all the subjects, rK39 was performed from plasma
samples according to manufacturer’s instruction pro-
vided as product inserts (the Kalazar Detect, InBios, Se-
attle, WA, USA).
DNA extraction
DNA was extracted from buffy coats using the commer-
cially available QIAamp DNA Blood Mini Kit (Qiagen,
Hilden, Germany) according to the manufacturer’s
instructions. After extraction, DNA was eluted in a final
volume of 0.2 mL of AE buffer (Qiagen Hilden, Germany).
Purity of DNA was measured in a Nano-drop (~5μL of
DNA) and was found to be satisfactory as an OD ratio
at A260/A280 was within the range of 1.7-1.9 in all
DNA samples.
Leishmania nested PCR (Ln-PCR)
For detection of parasite DNA, Leishmania specific
nested PCR (Ln-PCR) was performed with primers tar-
geting the parasites' small-subunit rRNA (SSU-rRNA)
region with some minor modifications as described in aprevious study [11]. For both the primary and nested
cycles, 2 μL of DNA was amplified in a final volume of
25 μL using the commercially available kit from GE
Healthcare (UK) which contained 200 μM each dNTP in
10 mM Tris–HCl, 50 mM KCl and 1.5 mM MgCl2,
2.5units of pure Taq DNA polymerase, BSA and stabili-
zers for each reaction. Prior to the second amplification
or nested PCR, the amplified products from the first run
were diluted at 1:20 with molecular grade water. An
additional 2.0 mM MgCl2 was added to the final reaction
mixture prior to the second round of amplification. The
final amplicons were visualized as 358 bp on 1.5% agar-
ose gel.
For the second round of amplification, 35 cycles were
used consisting of denaturation at 94°C for 30 s, 65°C
for 30 s, and 72°C for 30 s followed by a final extension
at 72°C for 5 min, in a BioRad’s MyCycler.
Loop-mediated isothermal amplification (LAMP)
The LAMP reaction was carried out according to the
original reports described by Tagaki et al. [14] with
minor modifications. Initially a primer mix was prepared
containing 40 pmol of each of FIP and BIP, and 5 pmol
of each of F3 and B3c primers. The final reaction mix-
ture of 25 μL contained 0.9 μL of primer mix, 1.4 mM
of each deoxynucleoside triphosphate, 0.8 M betaine and
2.5 μL of 10X ThermoPol Reaction Buffer (New England
Biolabs, Ipswich, MA), containing 20 mM Tris–HCl,
10 mM (NH4)2SO4, 10 mM KCl, 2 mMMgSO4, 0.1%
Triton X-100, pH 8.8, 25°C at final 1X and an additional
6 mM MgSO4 and 8 units of Bst polymerase large Frag-
ment (New England Biolabs, Ipswich, MA), and 2 μL of
buffy coat DNA. Each tube containing the reaction mix-
ture was sealed with paraffin (as LAMP causes massive
amplification which might result in contamination of
DNA) and incubated in a heat block at 62°C for 1 hour
and 30 min. During the course of the reaction, the bind-
ing of a reaction by-product (pyrophosphate ions) to
magnesium ion results in a white precipitate, entailing
the reaction fluid turbid. At the end of incubation, tur-
bidity was measured visually and the results were inter-
preted as positive or negative based on turbidity
(Figure 1).
Analytical sensitivity of LAMP
In order to compare the sensitivity of the LAMP assay,
in vitro promastigote culture (L. donovani MHOM/IN/
80/DD8) maintained in Novy-MacNeal-Nicolle medium
(NNN medium) by subpassaging was utilized for extrac-
tion of DNA. After extraction, the concentration of
DNA was measured by Nano-drop. A serial dilution of
cultured promastigote DNA starting from 100 pg to
0.1 fg were prepared in TE buffer (Qiagen Hilden, Ger-
many). The dilutions were amplified by both LAMP and
1 2 3 4 5 6 7 8 9
Figure 2 Sensitivity of LAMP reaction against serial dilution of
cultured promastigote DNA seen in 1.5% agarose gel
electrophoresis. Lanes 1 to 7 contain cultured promastigote
L. donavani DNA of 100 pg, 10 pg, 1 pg, 100 fg, 10 fg, 1 fg and
0.1 fg respectively; Lane 08 = negative control (PCR grade water) and
Lane 09 = 100 bp ladder.
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electrophoresis (Figure 2 & Figure 3).
Statistical analysis
Sensitivity and specificity were calculated using the
online Clinical Calculator 1. Data were entered and
clinical parameters were analyzed using the SPSS soft-
ware (version 11.5) for Windows. Sensitivities of
LAMP and Ln-PCR were compared by McNemar’s
test using a online calculator (http://www.vassarstats.
net/propcorr.html).
Results
Clinical parameters of the VL patients and controls are
shown in Table 1. Among 75 parasitologically confirmed
VL cases, 26 were female (34.67%) and 49 were male
(65.33%). The mean age of the VL patients was 17.8 years
(14.29-21.31, 95% CI) and that of the controls was
26.88 years (24.24-29.52, 95% CI).
Laboratory findings
Splenic smear microscopy
All the cases were confirmed to be true VL by the dem-
onstration of Leishmania amastigotes in the spleen
smear by microscopy (Table 2).
rK39 rapid test
All but one patient was found to be positive by rK39
RDT, indicating its sensitivity as 98.7% (99.93-91.78, 95%
CI), while all controls were found negative, yielding a
specificity of 100% (100–95.43, 95% CI). (Table 2).01 02
Figure 1 Visualization of LAMP products, 01 = A patient sample
found positive as indicated by turbidity, 02 = A control found
negative as indicated by absence of turbidity.Ln-PCR and LAMP
Among 75 confirmed VL cases, 72 were found to be
positive by Ln-PCR and all the controls were negative,
resulting in a sensitivity of 96% (98.96-87.97, 95% CI)
and specificity of 100% (100–95.43, 95% CI). Whereas,
68 of 75 VL cases were found to be positive by LAMP
and all the controls gave negative results, which yielded
a sensitivity of 90.7% (95.84-81.14, 95% CI) and a specifi-
city of 100% (100–95.43, 95% CI) (Table 2). All the la-
boratory findings are summarized in Table 2.
Further, LAMP assay was able to detect 66 of 72 Ln-
PCR positive cases and an additional 2 cases were found
positive by LAMP were negative by Ln-PCR.
Analytical sensitivity of LAMP
All the serially diluted samples were assessed for the
presence of promastigote DNA by both LAMP and Ln-
PCR. Ln-PCR was able to detect up to 0.1 fg of DNA
against up to 1 fg detected by LAMP assay (Additional
file 1).
Comparison of different methods
We compared the sensitivity and specificity between Ln-
PCR and LAMP assessed by the McNemar test.
1   2 3       4  5  6       7   8  9
Figure 3 Sensitivity of Ln-PCR against serial dilution of cultured
promastigote DNA seen in 1.5% agarose gel electrophoresis.
Lanes 1 to 7 contain cultured promastigote L. donovani DNA of
100 pg, 10 pg, 1 pg, 100 fg, 10 fg, 1 fg and 0.1 fg respectively;
Lane 08 = 100 bp ladder and Lane 09 = negative control
(PCR grade water).
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LAMP and Ln-PCR indicated no significant difference
(P value =0.28). As all the controls were negative by
both the methods, the McNemar test was not performed
for specificity.Discussion
Loop-mediated isothermal amplification originally devel-
oped by Notomi et al. [13] is a less expensive assay
which has now been utilized for the development of a
number of diagnostic methods to detect several African
trypanosome species [16-18], as well as malaria, tubercu-
losis, and filaria [19-23]. Despite VL being one of the
most important parasitic diseases, it still lacks a simple,
low-cost and sensitive diagnostic method. Therefore the
VL endemic regions in South Asia including Bangladesh
requires a definitive diagnostic method that can be per-
formed as a rapid test for VL patients living in immense
poverty.
In this study, we have validated the LAMP assay devel-
oped by Takagi et al. [14], with 75 confirmed VL cases
and 101 controls. It has revealed very encouragingresults compared to nested PCR assay which is being
used widely for the diagnosis of leishmaniasis. In a study
conducted by Takagi et al. [14], diagnostic sensitivity of
LAMP was evaluated for 10 confirmed VL patients and
08 (80%) were found to be positive for parasite DNA. In
another study conducted with 30 confirmed VL patients,
a sensitivity of 83% and specificity of 98% were reported
[24]. To compare the sensitivity and specificity of LAMP
using buffy coat DNA in our study consisting of 75 con-
firmed VL cases and 101 controls, we found a higher
sensitivity of 90.7% and specificity of 100%. A similar
range of sensitivity was reported by a number of investi-
gators using either whole blood or buffy coat (PBMC)
for PCR assays targeting the ITS or mini-exon regions
for DNA detection [25-27].
Although in this study we observed the performance
of LAMP to be slightly lower than Ln-PCR (sensitivity
96% and parasite detection rate is 0.1 parasite against 1
parasite by LAMP), yet it achieved better results than
shown in two previous studies. The reason for this could
be the use of buffy coat instead of whole blood. The spe-
cificity of the LAMP assay has been shown to be very
high as the assay utilizes four sets of primers targeting
six distinct target DNA sequences [16,28,29]. In our
study, although LAMP has failed marginally to satisfy
the WHO sensitivity level of >95% for any acceptable
test there are still several advantageous aspects of the
LAMP assay that need to be considered.
The very exciting features of LAMP assay include re-
quirement of just a heat block or even a simple water
bath instead of a costly thermal cycler, UV gel documen-
tation and transilluminator, which all are essential com-
ponents of conventional PCR [20,24,30,31]. Moreover,
the assay is performed under isothermal conditions at a
temperature range of 60°-65°C, circumventing the time
length involved in thermal changes of conventional PCR
and also prevents or lowers inhibition observed in its
later stages [28,32]. However, when the LAMP reaction
is performed in a water bath the chances of contamin-
ation tends to increase more and hence it is recom-
mended to wrap the cap of the tube with paraffin prior
to performing the LAMP assay. Further, the requirement
of electrical power supply to operate the water bath at
the resource limited settings can be avoided by the usage
of alternative power sources such as battery, exothermal
chemicals and solar power [31,32].
In addition, results of LAMP assay are interpreted by
observing turbidity [20,31,32] that reduces cost and time
of post conventional PCR analysis [16,24,28] as well as
eliminating the chance of contamination involved in
agarose gel electrophoresis [28]. It is also noted that gel
electrophoresis involves handling of potent carcinogenic
agents such as ethidium bromide which poses a poten-
tial threat for those handling it in the laboratory.
Table 1 Clinical parameters of cases and controls
VL cases
Number Percentage%
Male 49 65.33
Female 26 34.67
Age 1 y- 60 y (mean 17.80 years) NA
Controls
Male 70 69.31
Female 31 30.69
Age 2 y- 70 y (mean 26.88 years) NA
Clinical signs and symptoms of VL cases
Duration of fever (in weeks) 4-52 weeks (mean = 20 weeks)
Anaemia 74 98.7
Weight Loss 75 100
Hepatomegaly 58 77.3
Splenomegaly 74 98.7
Blackening 72 96.0
Jaundice 1 1.3
Bleeding 6 8.0
Pancytopenia 29 38.7
ESR 25-175 (mean = 102.81) NA
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LAMP assay is active at relatively high temperatures,
which minimizes the possibility of non-specific priming
[16] and is more resistant to inhibitors that prevent con-
ventional PCR [19]. Alongside, the isothermal condition
of the assay lowers inhibition observed in the later stages
of conventional PCR [29].
Several reports have indicated the usefulness of using
heat-treated samples as a template DNA source without
compromising the sensitivity, and thus eliminating the
need for DNA extraction which reduces both time and
cost [16,19,28,31]. Reports from a previous study indi-
cated that LAMP assay for malaria diagnosis using heat
treated blood was priced between US$0.4 and US$0.7,
that is lower than currently available RDT's [19]. How-
ever, in this study we were not able to validate our assay
with heat-treated blood samples for the diagnosis of VL.Table 2 Sensitivity and Specificity of different methods for di
Diagnostic
Method
Sensitivity in
VL group (n = 75),
% (95% CI)
Speci
Endemic
Healthy Control
(n = 25),% (95% CI)
Non-endem
Healthy Con
(n = 26),% (
rK39 ICT 98.67 100 100
(99.93-91.78) (100–95.43) (100–95.43)
Ln-PCR 96 100 100
(98.96-87.97) (100–95.43) (100–95.43)
LAMP 90.7 100 100
(95.84-81.14) (100–95.43) (100–95.43)We speculate that, validation of heat treated buffy coat
as a DNA source could further minimize the cost for
diagnosis if it can be established for leishmaniasis. Fur-
ther, there is scope to improve the sensitivity of LAMP
in the diagnosis of VL if some unexpected problems
associated with sample storage and transportation can
be minimized. In our case, we collected VL samples
from RMCH and stored them there for a certain length
of period, this site is about 300 km away from ICDDR,
B. Had these steps been avoided, we believe that the sen-
sitivity of LAMP in our study might be slightly
increased.
Conclusion
To achieve the goal of a VL elimination program, devel-
opment and introduction of rapid and less expensive
diagnosis through non-invasive or minimally invasiveagnosis of VL
ficity in control groups, (n = 101),% (n)
ic
trol
95% CI)
Other Disease
Control (n = 25),
% (95% CI)
Tuberculosis
control (n = 25),
% (95% CI)
Specificity Total
group, (n = 101),
% (95% CI)
100 100 100
(100–95.43) (100–95.43) (100–95.43)
100 100 100
(100–95.43) (100–95.43) (100–95.43)
100 100 100
(100–95.43) (100–95.43) (100–95.43)
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has the potential to full-fill this requirement. So we rec-
ommend LAMP as a future novel VL diagnosis tool in
the field condition, but before being introduced in the
field further evaluation is necessary with larger case and
control groups using heat-treated blood samples.
Additional file
Additional file 1: STARD checklist for reporting of studies of
diagnostic accuracy.
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